deferoxamine mesylate
deferoxamine mesylate is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Desferal. Available dosage forms: injection, powder, for solution, injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- deferoxamine mesylate
- Brand Names
- Desferal
- Application Number
- NDA016267
- Sponsor
- MITEM PHARMA
- NDC Codes
- 2
- Dosage Forms
- INJECTION, POWDER, FOR SOLUTION, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR
- Active Ingredients
- DEFEROXAMINE MESYLATE
Indications and Usage
1 INDICATIONS AND USAGE Deferoxamine Mesylate for Injection is an iron-chelating agent indicated: • As an adjunct to standard measures for the treatment of acute iron intoxication. ( 1.1 ) • For the treatment of transfusional iron overload in patients with chronic anemia. ( 1.2 ) Limitations of Use Deferoxamine Mesylate for Injection is not indicated for the treatment of primary hemochromatosis (since phlebotomy is the method of choice for removing excess iron in this disorder). 1.1 Acute Iron Intoxication Deferoxamine Mesylate for Injection is indicated as an adjunct to standard measures for the treatment of acute iron intoxication. 1.2 Chronic Iron Overload Deferoxamine Mesylate for Injection is indicated for the treatment of transfusional iron overload in patients with chronic anemia. 1.3 Limitations of Use Deferoxamine Mesylate for Injection is not indicated for the treatment of primary hemochromatosis (since phlebotomy is the method of choice for removing excess iron in this disorder).